CDC recommendations<\/h1><\/div>\n\n\n\n<\/div>\n<\/div><\/div><\/div>\n\n\n\n\nCAPVAXIVE is a single-dose PCV recommended by the CDC1<\/sup>\u2028
updated October 2024<\/mark><\/h2><\/div>\n\n\n\n<\/div>\n\n\n\n\n![\"CAPVAXIVE](\"https:\/\/www.merckvaccines.com\/capvaxive\/wp-content\/uploads\/sites\/153\/2026\/03\/home_table.png\" "\\"\\"")
![\"CAPVAXIVE](\"https:\/\/www.merckvaccines.com\/capvaxive\/wp-content\/uploads\/sites\/153\/2026\/03\/capvaxive_homepage_cdc-recommendations_mobile-1.svg\" "\\"\\"")
<\/figure><\/div><\/div>\n<\/div><\/div><\/div>\n\n\n\n\n<\/div>\n\n\n\n *<\/sup>Routine if PCV13 was administered at any age and PPSV23 was administered before age 65 with the last pneumococcal vaccine being at least 5 years prior. Shared clinical decision-making if PCV13 was administered at any age and PPSV23 was administered at or after the age of 65 and the last pneumococcal vaccine was at least 5 years prior.1<\/sup><\/p><\/div><\/div>\n\n\n\n<\/div>\n\n\n\n \u2020<\/sup>Certain chronic medical conditions (eg, diabetes, chronic heart disease, chronic lung disease, or chronic liver disease) or behavioral risk factors (eg, smoking or alcoholism).1<\/sup><\/p><\/div><\/div>\n\n\n\n<\/div>\n\n\n\n \u2021<\/sup>See ACIP recommendations for full list of immunocompromising conditions, including HIV.1<\/sup><\/p><\/div><\/div>\n\n\n\n<\/div>\n\n\n\n \u00a7<\/sup>Also applies to patients with certain immunocompromising conditions who have received PCV13 followed by 2 doses of PPSV23.1<\/sup><\/p><\/div><\/div>\n<\/div><\/div><\/div>\n\n\n\n<\/div>\n\n\n\n\n\n\n\n![\"\"\/](\"https:\/\/www.merckvaccines.com\/capvaxive\/wp-content\/uploads\/sites\/153\/2026\/03\/icon4.png\")
<\/picture><\/figure><\/div>How do I administer CAPVAXIVE?<\/mark><\/h2>\nGive 1 dose to your appropriate adult patients.<\/p>\n\n\n\n
CAPVAXIVE is a single-dose PCV recommended by the CDC1<\/sup>\u2028
updated October 2024<\/mark><\/h2><\/div>\n\n\n\n<\/div>\n\n\n\n\n<\/figure><\/div><\/div>\n<\/div><\/div><\/div>\n\n\n\n\n<\/div>\n\n\n\n *<\/sup>Routine if PCV13 was administered at any age and PPSV23 was administered before age 65 with the last pneumococcal vaccine being at least 5 years prior. Shared clinical decision-making if PCV13 was administered at any age and PPSV23 was administered at or after the age of 65 and the last pneumococcal vaccine was at least 5 years prior.1<\/sup><\/p><\/div><\/div>\n\n\n\n<\/div>\n\n\n\n \u2020<\/sup>Certain chronic medical conditions (eg, diabetes, chronic heart disease, chronic lung disease, or chronic liver disease) or behavioral risk factors (eg, smoking or alcoholism).1<\/sup><\/p><\/div><\/div>\n\n\n\n<\/div>\n\n\n\n \u2021<\/sup>See ACIP recommendations for full list of immunocompromising conditions, including HIV.1<\/sup><\/p><\/div><\/div>\n\n\n\n<\/div>\n\n\n\n \u00a7<\/sup>Also applies to patients with certain immunocompromising conditions who have received PCV13 followed by 2 doses of PPSV23.1<\/sup><\/p><\/div><\/div>\n<\/div><\/div><\/div>\n\n\n\n<\/div>\n\n\n\n\n\n\n\n<\/picture><\/figure><\/div>How do I administer CAPVAXIVE?<\/mark><\/h2>\nGive 1 dose to your appropriate adult patients.<\/p>\n\n\n\n
<\/figure><\/div><\/div>\n<\/div><\/div><\/div>\n\n\n\n *<\/sup>Routine if PCV13 was administered at any age and PPSV23 was administered before age 65 with the last pneumococcal vaccine being at least 5 years prior. Shared clinical decision-making if PCV13 was administered at any age and PPSV23 was administered at or after the age of 65 and the last pneumococcal vaccine was at least 5 years prior.1<\/sup><\/p><\/div><\/div>\n\n\n\n \u2020<\/sup>Certain chronic medical conditions (eg, diabetes, chronic heart disease, chronic lung disease, or chronic liver disease) or behavioral risk factors (eg, smoking or alcoholism).1<\/sup><\/p><\/div><\/div>\n\n\n\n \u2021<\/sup>See ACIP recommendations for full list of immunocompromising conditions, including HIV.1<\/sup><\/p><\/div><\/div>\n\n\n\n \u00a7<\/sup>Also applies to patients with certain immunocompromising conditions who have received PCV13 followed by 2 doses of PPSV23.1<\/sup><\/p><\/div><\/div>\n<\/div><\/div><\/div>\n\n\n\n Give 1 dose to your appropriate adult patients.<\/p>\n\n\n\n<\/picture><\/figure><\/div>How do I administer CAPVAXIVE?<\/mark><\/h2>